FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vered Stearns

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Physiology

Procedures

Co-author Network

Publications

TOP 3
MICHELLE RUDEK-RENAUT; Vered Stearns; Stanley P Watkins; Laurie A Wright; Ming Zhao; Deborah K Armstrong; Roisin M Connolly; Nancy E Davidson; John H Fetting; Elizabeth Garrett-Mayer; Janelle M Hoskins; Stacie C Jeter; Howard L McLeod; Antonio C Wolff
Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer.
Paul E Goss; James N Ingle; David B Johnson; Istvan Lang; Pedro E R Liedke; Edith A Perez; Kathleen I Pritchard; Manuela Rabaglio; Rafat H Ansari; G Thomas Budd; Haji Chalchal; Judy-Anne W Chapman; David P D'Souza; Catherine Elliott; Matthew J Ellis; Karen Gelmon; George W Sledge; Silvana Spadafora; Vered Stearns; Richard Tozer; Lois E Shepherd
Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial.
N Lynn Henry; Kelley Kidwell; Lang Li; Anne T Nguyen; Steffi Oesterreich; Santosh Philips; James M Rae; Todd C Skaar; Vered Stearns; Anna Maria Storniolo; Janet S Carpenter; Jessica Dantzer; Zeruesenay Desta; Christina Gersch; Daniel F Hayes; David A Flockhart
Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vered Stearns (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: MICHELLE RUDEK-RENAUT; Vered Stearns; Stanley P Watkins; Laurie A Wright; Ming Zhao; Deborah K Armstrong; Roisin M Connolly; Nancy E Davidson; John H Fetting; Elizabeth Garrett-Mayer; Janelle M Hoskins; Stacie C Jeter; Howard L McLeod; Antonio C Wolff
Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer.
Breast cancer research and treatment 2013;139(1):135-43.
2013: Paul E Goss; James N Ingle; David B Johnson; Istvan Lang; Pedro E R Liedke; Edith A Perez; Kathleen I Pritchard; Manuela Rabaglio; Rafat H Ansari; G Thomas Budd; Haji Chalchal; Judy-Anne W Chapman; David P D'Souza; Catherine Elliott; Matthew J Ellis; Karen Gelmon; George W Sledge; Silvana Spadafora; Vered Stearns; Richard Tozer; Lois E Shepherd
Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(11):1398-404.
2013: N Lynn Henry; Kelley Kidwell; Lang Li; Anne T Nguyen; Steffi Oesterreich; Santosh Philips; James M Rae; Todd C Skaar; Vered Stearns; Anna Maria Storniolo; Janet S Carpenter; Jessica Dantzer; Zeruesenay Desta; Christina Gersch; Daniel F Hayes; David A Flockhart
Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer.
Breast cancer research and treatment 2013;138(3):807-16.
2013: Ting Bao; Kelly Betts; Ling Cai; Saranya Chumsri; Mitch Dowsett; Elizabeth Folkerd; Jon T Giles; Jeff Gould; Stacie Jeter; Michelle Medeiros; Harvinder Singh; Nancy Tait; Ming Tan; Karineh Tarpinian; Katherine Tkaczuk; Deborah K Armstrong; Vered Stearns
A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors.
Breast cancer research and treatment 2013;138(1):167-74.
2012: Joseph A Sparano; Vered Stearns; Molin Wang; Antonio C Wolff; William C Wood; Fengmin Zhao; John H Fetting; Jennifer A Ligibel; Silvana Martino; Edith A Perez; Tom Saphner; George W Sledge; Nancy E Davidson
Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer.
Cancer 2012;118(23):5937-46.
2012: Roisin Connolly; Vered Stearns
Epigenetics as a therapeutic target in breast cancer.
Journal of mammary gland biology and neoplasia 2012;17(3-4):191-204.
2012: Lauren Nicole Bell; Zeruesenay Desta; David A Flockhart; Daniel F Hayes; N Lynn Henry; Lang Li; Anne Thi Phuong Nguyen; Vered Stearns; Anna Maria Storniolo; Antonio C Wolff
Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozole.
Journal of clinical pharmacology 2012;52(12):1852-60.
2012: Yong Soon Chun; Roeland F de Wilde; Seung-Mo Hong; David L Huso; Anirban Maitra; Dipankar Pramanik; Michelle A Rudek; Vered Stearns; Savita Bisht; Venugopal Chenna; Takahiro Yoshida; Zhe Zhang; Ming Zhao; Saraswati Sukumar
Intraductal administration of a polymeric nanoparticle formulation of curcumin (NanoCurc) significantly attenuates incidence of mammary tumors in a rodent chemical carcinogenesis model: Implications for breast cancer chemoprevention in at-risk populations.
Carcinogenesis 2012;33(11):2242-9.
2012: Bryan P Schneider; George W Sledge; Nancy E Davidson; Vicky Jones; Silvana Martino; Edith A Perez; Tom Saphner; Vered Stearns; Molin Wang; Antonio C Wolff; William C Wood; Fengmin Zhao; Joseph A Sparano
Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(25):3051-7.
2012: Jennifer Wenzel; Linda P Darrell; Randy A Jones; Rachel Klimmek; Sharon Krumm; Danny Y Song; Vered Stearns; Jean G Ford
Cancer support and resource needs among African American older adults.
Clinical journal of oncology nursing 2012;16(4):372-7.
2012: Yong Soon Chun; David L Huso; Richard J Jones; Tsuyoshi Mori; Brandy Perkins; Vered Stearns; Takahiro Yoshida; Zhe Zhang; Saraswati Sukumar
Intraductally administered pegylated liposomal doxorubicin reduces mammary stem cell function in the mammary gland but in the long term, induces malignant tumors.
Breast cancer research and treatment 2012;135(1):201-8.
2012: Michaela J Higgins; Peng Huang; Danijela Jelovac; Stacie C Jeter; KATHLEEN MURPHY; George R Oliver; Penny Powers; Carol Riley; Shannon Slater; Vered Stearns; Antonio C Wolff; Jane Zorzi; Philipp Angenendt; Pedram Argani; Kurtis E Bachman; Evan Barnathan; Brian Blair; Leslie Cope; Frank Diehl; Leisha A Emens; John H Fetting; Joel Greshock; Ben Ho Park
Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(12):3462-9.
2012: Bhuvaneswari Ramaswamy; Charles L Shapiro; G Somlo; Vered Stearns; R Swaby; K Bhalla; P Christos; E Chuang; B Cohen; Igor Espinoza-Delgado; Warren C Fiskus; M Goetz; D L Hershman; Thehang Luu; C Pellegrino; Joseph A Sparano
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo.
Breast cancer research and treatment 2012;132(3):1063-72.
2012: James M Rae; Janine Salter; Ivana Sestak; Vered Stearns; Jacklyn N Thibert; Jack Cuzick; Mitch Dowsett; Suzy Drury; Daniel F Hayes; Ben P Haynes
CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients.
Journal of the National Cancer Institute 2012;104(6):452-60.
2012: Hsing-Chen Tsai; Leander Van Neste; Alana L Welm; Lonny Brett Yarmus; Ray-Whay Chiu Yen; NITA AHUJA; Stephen B Baylin; ROBERT BEATY; Malcolm V Brock; Yi Cai; DAVID FELLER-KOPMAN; Kirsten M Harbom; James Harris; Jean-Pierre J Issa; YOON YOUNG JANG; Huili Li; Yi-Chun Lin; William Matsui; Il Minn; Emmanouil Pappou; Feyruz V Rassool; Carine Robert; Saul J Sharkis; James J Shin; Vered Stearns; Cynthia A Zahnow
Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells.
Cancer cell 2012;21(3):430-46.
2012: N Lynn Henry; Suzanne Lemler; Lang Li; Anne T Nguyen; Vered Stearns; Faouzi Azzouz; Zeruesenay Desta; David A Flockhart; Jill Hayden; Daniel F Hayes; Karineh Tarpinian; Elizabeth Yakim; Anna Maria Storniolo
Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(9):936-42.
2012: Joseph A Sparano; Vered Stearns; Molin Wang; Antonio C Wolff; William C Wood; Fengmin Zhao; Jennifer A Ligibel; Silvana Martino; Edith A Perez; Tom Saphner; George W Sledge; Nancy E Davidson
Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.
Journal of the National Cancer Institute 2012;104(5):406-14.
2012: R J Hartmaier; J Hayden; Daniel F Hayes; N Lynn Henry; A V Lee; L Li; S E McGuire; A T Nguyen; Bert W O'Malley; C K Osborne; S Philips; James M Rae; A S Richter; J Z Sallit; T C Skaar; Vered Stearns; J Wang; J Xu; Faouzi Azzouz; P H Brown; D A Flockhart; R M Gillihan; Steffi Oesterreich
A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone.
Molecular endocrinology (Baltimore, Md.) 2012;26(2):220-7.
2012: Michaela J Higgins; Stacie C Jeter; NAGI KHOURI; Pendleton P Powers; Tatiana M Prowell; James M Rae; Shannon A Slater; Deborah K Armstrong; Amanda Blackford; Roger S Blumenthal; Celia Byrne; Nancy E Davidson; Mitchell Dowsett; Leisha A Emens; John H Fetting; Elizabeth Folkerd; Judy E Garber; Hannah Green; Jacklyn N Thibert; Antonio C Wolff; Vered Stearns
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer.
Breast cancer research and treatment 2012;131(3):915-24.
2012: Aditya Bardia; Roger S Blumenthal; Nancy E Davidson; Andrew Defilippis; John H Fetting; David A Flockhart; Jill Hayden; Daniel F Hayes; N Lynn Henry; Stacie Jeter; Anne Nguyen; Pamela Ouyang; Anna Maria Storniolo; Karineh Tarpinian; Antonio C Wolff; Zhe Zhang; Erin T Arieas; Deborah K Armstrong; M Dominique Ashen; Vered Stearns
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer.
Breast cancer research and treatment 2012;131(3):907-14.
2012: Santosh Philips; James M Rae; Vered Stearns; Anna Maria Storniolo; David A Flockhart; Daniel F Hayes; N Lynn Henry; Steffi Oesterreich; Todd C Skaar
Whole genome amplification of DNA for genotyping pharmacogenetics candidate genes.
Frontiers in pharmacology 2012;3():54.
2012: Ting Bao; Amanda L Blackford; Vered Stearns
Effect of simvastatin on the pharmacokinetics of anastrozole.
Breast cancer research and treatment 2012;131(2):709-11.
2011: Tatiana M Prowell; Todd C Skaar; Karineh S Tarpinian; Antonio C Wolff; Laurie A Wright; Deborah K Armstrong; Amanda L Blackford; Celia Byrne; Nancy E Davidson; Michele G Donehower; Mitchell Dowsett; Leisha A Emens; John H Fetting; Elizabeth Folkerd; Elizabeth Garrett-Mayer; Stacie C Jeter; NAGI KHOURI; Pendleton P Powers; Vered Stearns
Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole.
Cancer prevention research (Philadelphia, Pa.) 2011;4(12):1993-2001.
2011: Z Desta; Daniel F Hayes; N Lynn Henry; E Hoffmann; Landry K Kamdem; Y Kreutz; L Li; A T Nguyen; Todd C Skaar; Vered Stearns; Anna Maria Storniolo; R F Tyndale; David A Flockhart
Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and age.
Clinical pharmacology and therapeutics 2011;90(5):693-700.
2011: Vered Stearns; Karineh Tarpinian; Theodore Tsangaris; Takahiro Yoshida; Zhe Zhang; Regina J Brown; Edward Gabrielson; David L Huso; LISA JACOBS; Stacie Jeter; NAGI KHOURI; Scott L Kominsky; Julie R Lange; Tsuyoshi Mori; Penny Powers; Michelle A Rudek; Saraswati Sukumar
Preclinical and clinical evaluation of intraductally administered agents in early breast cancer.
Science translational medicine 2011;3(106):106ra108.
2011: Michael A Jacobs; Stacie Jeter; Ronald Ouwerkerk; David A Bluemke; Edward Gabrielson; Richard L Wahl; Hind Warzecha; Antonio C Wolff; Vered Stearns
Monitoring of neoadjuvant chemotherapy using multiparametric, ²³Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer.
Breast cancer research and treatment 2011;128(1):119-26.
2011: Radharani Marik; Madhan Allu; RAVI ANCHOORI; Vered Stearns; Christopher B Umbricht; Saeed R Khan
Potent genistein derivatives as inhibitors of estrogen receptor alpha-positive breast cancer.
Cancer biology & therapy 2011;11(10):883-92.
2011: Roisin M Connolly; MICHELLE RUDEK-RENAUT; Elizabeth Garrett-Mayer; Stacie C Jeter; Michele G Donehower; Laurie A Wright; Ming Zhao; John H Fetting; Leisha A Emens; Vered Stearns; Nancy E Davidson; Sharyn D Baker; Antonio C Wolff
Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancer.
Breast cancer research and treatment 2011;127(1):153-62.
2011: N Lynn Henry; Vered Stearns
One size does not fit all: quality of life during adjuvant aromatase inhibitor therapy.
Breast cancer research and treatment 2011;125(3):751-3.
2011: Kevin Rand; J L Otte; David A Flockhart; Daniel F Hayes; Anna Maria Storniolo; Vered Stearns; N Lynn Henry; Anne Nguyen; S Lemler; J Hayden; S Jeter; Janet S Carpenter
Modeling hot flushes and quality of life in breast cancer survivors.
Climacteric : the journal of the International Menopause Society 2011;14(1):171-80.
2011: Stéphanie Gaillard; Vered Stearns
Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management.
Breast cancer research : BCR 2011;13(2):205.
2011: Michaela J Higgins; Vered Stearns
Pharmacogenetics of endocrine therapy for breast cancer.
Annual review of medicine 2011;62():281-93.
2010: Landry K Kamdem; Yong Liu; Vered Stearns; Susan A Kadlubar; Jacqueline Ramirez; Stacie Jeter; Karineh Shahverdi; Bryan A Ward; Evan Ogburn; Mark J Ratain; David A Flockhart; Zeruesenay Desta
In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole.
British journal of clinical pharmacology 2010;70(6):854-69.
2010: Michael A Jacobs; Vered Stearns; Antonio C Wolff; Katarzyna J Macura; Pedram Argani; NAGI KHOURI; Theodore Tsangaris; Peter B Barker; Nancy E Davidson; Zaver M Bhujwalla; David A Bluemke; Ronald Ouwerkerk
Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer.
Academic radiology 2010;17(12):1477-85.
2010: James N Ingle; Daniel J Schaid; Paul E Goss; Mohan Liu; Taisei Mushiroda; Judy-Anne W Chapman; Michiaki Kubo; Gregory D Jenkins; Anthony Batzler; Lois Shepherd; Joseph Pater; Liewei Wang; Matthew J Ellis; Vered Stearns; Daniel C Rohrer; Matthew P Goetz; Kathleen I Pritchard; David A Flockhart; Yusuke Nakamura; Richard M Weinshilboum
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(31):4674-82.
2010: Daniel F Hayes; T C Skaar; James M Rae; N Lynn Henry; A T Nguyen; Vered Stearns; Liwu Li; S Philips; Z Desta; David A Flockhart
Estrogen receptor genotypes, menopausal status, and the effects of tamoxifen on lipid levels: revised and updated results.
Clinical pharmacology and therapeutics 2010;88(5):626-9.
2010: N Lynn Henry; Jon A Jacobson; Mousumi Banerjee; Jill Hayden; Jeffrey B Smerage; Catherine Van Poznak; Anna Maria Storniolo; Vered Stearns; Daniel F Hayes
A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography.
Cancer 2010;116(18):4360-7.
2010: Aditya Bardia; Vered Stearns
Personalized tamoxifen: a step closer but miles to go.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(17):4308-10.
2010: Harold J Burstein; Ann Alexis Prestrud; Jerome Seidenfeld; Holly Anderson; Thomas A Buchholz; Nancy E Davidson; Karen E Gelmon; Sharon H Giordano; Clifford Hudis; Jennifer Malin; Eleftherios P Mamounas; Diana Rowden; Alexander J Solky; MaryFran Sowers; Vered Stearns; Eric P Winer; Mark R Somerfield; Jennifer J Griggs
American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(23):3784-96.
2010: CLAIRE SNYDER; Amanda Blackford; Julie R Brahmer; Michael A Carducci; Roberto Pili; Vered Stearns; Antonio C Wolff; Sydney M Dy; Albert W Wu
Needs assessments can identify scores on HRQOL questionnaires that represent problems for patients: an illustration with the Supportive Care Needs Survey and the QLQ-C30.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2010;19(6):837-45.
2010: N Lynn Henry; D Pchejetski; R A'Hern; A T Nguyen; P Charles; J Waxman; Liwu Li; Anna Maria Storniolo; Daniel F Hayes; David A Flockhart; Vered Stearns; J Stebbing
Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study.
British journal of cancer 2010;103(3):291-6.
2010: Gary Elkins; Joel Marcus; Jennifer Bunn; Michelle Perfect; Lynn Palamara; Vered Stearns; Jacqueline Dove
Preferences for hypnotic imagery for hot-flash reduction: a brief communication.
The International journal of clinical and experimental hypnosis 2010;58(3):345-9.
2010: Radharani Marik; Mary Jo Fackler; Edward Gabrielson; Martha A Zeiger; Saraswati Sukumar; Vered Stearns; Christopher B Umbricht
DNA methylation-related vitamin D receptor insensitivity in breast cancer.
Cancer biology & therapy 2010;10(1):44-53.
2010: LISA JACOBS; Saraswati Sukumar; Vered Stearns
Intraductal therapy for the prevention of breast cancer.
Current opinion in investigational drugs (London, England : 2000) 2010;11(6):646-52.
2010: Ting Bao; John H Fetting; Laura Mumford; Jane Zorzi; Karineh Shahverdi; Stacie Jeter; H Franklin Herlong; Vered Stearns; Linda Lee
Severe prolonged cholestatic hepatitis caused by exemestane.
Breast cancer research and treatment 2010;121(3):789-91.
2010: Aditya Bardia; Vered Stearns
Personal breast: customizing agents and biomarkers for optimal adjuvant endocrine therapy.
Breast cancer research and treatment 2010;120(2):437-9.
2010: Silvana Borges; Zeruesenay Desta; Yan Jin; Azzouz Faouzi; Jason D Robarge; Sanosh Philips; Santosh Philip; Anne Nguyen; Vered Stearns; Daniel F Hayes; James M Rae; Todd C Skaar; David A Flockhart; Lang Li
Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients.
Journal of clinical pharmacology 2010;50(4):450-8.
2010: Thushangi N Pathiraja; Vered Stearns; Steffi Oesterreich
Epigenetic regulation in estrogen receptor positive breast cancer--role in treatment response.
Journal of mammary gland biology and neoplasia 2010;15(1):35-47.
2010: Roisin Connolly; Vered Stearns
A multidisciplinary approach to neoadjuvant therapy for primary operable breast cancer. Challenges and opportunities.
Oncology (Williston Park, N.Y.) 2010;24(2):135-43.
2010: Saranya Chumsri; Stacie Jeter; LISA JACOBS; HIND NASSAR; Deborah K Armstrong; Leisha A Emens; John H Fetting; Julie R Lange; Carol Riley; Theodore Tsangaris; Antonio C Wolff; RICHARD ZELLARS; Zhe Zhang; Vered Stearns
Pathologic complete response to preoperative sequential doxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive breast cancer.
Clinical breast cancer 2010;10(1):40-5.
2010: N Lynn Henry; Anne Nguyen; F Azzouz; Liwu Li; J Robarge; S Philips; D Cao; T C Skaar; James M Rae; Anna Maria Storniolo; David A Flockhart; Daniel F Hayes; Vered Stearns
Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy.
British journal of cancer 2010;102(2):294-300.
2010: Michaela J Higgins; Vered Stearns
CYP2D6 polymorphisms and tamoxifen metabolism: clinical relevance.
Current oncology reports 2010;12(1):7-15.
2009: Leisha A Emens; Justin M Asquith; James M Leatherman; BARRY KOBRIN; Silvia Petrik; Marina Laiko; Joy Levi; Maithili M Daphtary; Barbara A Biedrzycki; Antonio C Wolff; Vered Stearns; Mary L Disis; Xiaobu Ye; Steven Piantadosi; John H Fetting; Nancy E Davidson; Elizabeth M Jaffee
Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(35):5911-8.
2009: Suresh Mohla; Vered Stearns; N Sathyamoorthy; Michael G Rosenfeld; Peter Nelson
The biology of hormone refractory breast and prostate cancer: An NCI workshop report.
Cancer biology & therapy 2009;8(21):1975-85.
2009: CLAIRE SNYDER; Elizabeth Garrett-Mayer; Amanda L Blackford; Julie R Brahmer; Michael A Carducci; Roberto Pili; Vered Stearns; Antonio C Wolff; Sydney M Dy; Albert W Wu
Concordance of cancer patients' function, symptoms, and supportive care needs.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2009;18(8):991-8.
2009: N Lynn Henry; James M Rae; Lang Li; Faouzi Azzouz; Todd C Skaar; Zereunesay Desta; Matthew J Sikora; Santosh Philips; Anne T Nguyen; Anna Maria Storniolo; Daniel F Hayes; David A Flockhart; Vered Stearns
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort.
Breast cancer research and treatment 2009;117(3):571-5.
2009: Charles L Loprinzi; Brent Diekmann; Paul J Novotny; Vered Stearns; Jeff A Sloan
Newer antidepressants and gabapentin for hot flashes: a discussion of trial duration.
Menopause (New York, N.Y.) 2009;16(5):883-7.
2009: Ani Balmanoukian; Zhe Zhang; Stacie Jeter; Shannon Slater; Deborah K Armstrong; Leisha A Emens; John H Fetting; Antonio C Wolff; Nancy E Davidson; LISA JACOBS; Julie R Lange; Theodore Tsangaris; RICHARD ZELLARS; Edward Gabrielson; Vered Stearns
African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(22):e35-7; author reply e38-9.
2009: Michaela J Higgins; Vered Stearns
Understanding resistance to tamoxifen in hormone receptor-positive breast cancer.
Clinical chemistry 2009;55(8):1453-5.
2009: James M Rae; M J Sikora; N Lynn Henry; Lang Li; S Kim; S Oesterreich; T C Skaar; A T Nguyen; Z Desta; Anna Maria Storniolo; David A Flockhart; Daniel F Hayes; Vered Stearns
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients.
The pharmacogenomics journal 2009;9(4):258-64.
2009: Julie L Otte; David A Flockhart; Daniel F Hayes; Anna Maria Storniolo; Vered Stearns; Bryan Schneider; N Lynn Henry; Faouzi Azzouz; Anne Nguyen; Suzanne Lemler; Jill Hayden; Stacie Jeter; Laurie Wright; Janet S Carpenter
Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy.
Menopause (New York, N.Y.) 2009;16(4):653-9.
2009: Charles L Loprinzi; Jeff Sloan; Vered Stearns; Rebecca Slack; Malini Iyengar; Brent Diekmann; Gretchen Kimmick; James Lovato; Paul Gordon; Kishan Pandya; Thomas Guttuso; Debra L. Barton; Paul J Novotny
Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(17):2831-7.
2009: RICHARD ZELLARS; Vered Stearns; Deborah A Frassica; Fariba Asrari; Theodore Tsangaris; Lee Myers; Shirley DiPasquale; Julie R Lange; LISA JACOBS; Leisha A Emens; Deborah K Armstrong; John H Fetting; Elizabeth Garrett-Mayer; Nancy E Davidson; Antonio C Wolff
Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(17):2816-22.
2009: WEN SHEN; Vered Stearns
Treatment strategies for hot flushes.
Expert opinion on pharmacotherapy 2009;10(7):1133-44.
2009: Susanne Briest; Vered Stearns
Tamoxifen metabolism and its effect on endocrine treatment of breast cancer.
Clinical advances in hematology & oncology : H&O 2009;7(3):185-92.
2009: Michaela J Higgins; James M Rae; David A Flockhart; Daniel F Hayes; Vered Stearns
Pharmacogenetics of tamoxifen: who should undergo CYP2D6 genetic testing?
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(2):203-13.
2008: Yan Jin; Daniel F Hayes; Lang Li; Jason D Robarge; Todd C Skaar; Santosh Philips; Anne Nguyen; Anne F Schott; Jill Hayden; Suzanne Lemler; Anna Maria Storniolo; David A Flockhart; Vered Stearns
Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(36):5849-54.
2008: N Lynn Henry; Jon T Giles; Vered Stearns
Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management.
Oncology (Williston Park, N.Y.) 2008;22(12):1401-8.
2008: Gary Elkins; Joel Marcus; Vered Stearns; Michelle Perfect; Mohammad Hasan Rajab; Christopher Ruud; Lynne Palamara; Timothy Keith
Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(31):5022-6.
2008: N Lynn Henry; Vered Stearns; David A Flockhart; Daniel F Hayes; Michelle B Riba
Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.
The American journal of psychiatry 2008;165(10):1251-5.
2008: Martha Hickey; C Saunders; A Partridge; Nanette Santoro; H Joffe; Vered Stearns
Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(10):1669-80.
2008: N Lynn Henry; Jon T Giles; Dennis Ang; Monika Mohan; Dina Dadabhoy; Jason Robarge; Jill Hayden; Suzanne Lemler; Karineh Shahverdi; Penny Powers; Lang Li; David A Flockhart; Vered Stearns; Daniel F Hayes; Anna Maria Storniolo; Daniel J Clauw
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors.
Breast cancer research and treatment 2008;111(2):365-72.
2008: CLAIRE SNYDER; Elizabeth Garrett-Mayer; Julie R Brahmer; Michael A Carducci; Roberto Pili; Vered Stearns; Antonio C Wolff; Sydney M Dy; Albert W Wu
Symptoms, supportive care needs, and function in cancer patients: how are they related?
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2008;17(5):665-77.
2008: Daniel F Hayes; Vered Stearns; James M Rae; David Flockhart
A model citizen? Is tamoxifen more effective than aromatase inhibitors if we pick the right patients?
Journal of the National Cancer Institute 2008;100(9):610-3.
2008: N I Ntukidem; A T Nguyen; Vered Stearns; M Rehman; Anne F Schott; T Skaar; Y Jin; P Blanche; L Li; S Lemler; J Hayden; R M Krauss; Z Desta; D A Flockhart; Daniel F Hayes
Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen.
Clinical pharmacology and therapeutics 2008;83(5):702-10.
2008: Vered Stearns; James M Rae
Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response?
Expert reviews in molecular medicine 2008;10():e34.
2008: Vered Stearns
A diet low in fat and high in vegetables, fruit, and fiber following breast cancer treatment did not reduce new breast cancer events.
ACP journal club 2008;148(1):8.
2008: Susanne Briest; Vered Stearns
Adjuvant aromatase inhibitors and emerging quality-of-life considerations.
Expert review of anticancer therapy 2008;8(1):1-4.
2007: Tatiana M Prowell; Vered Stearns
Extended adjuvant therapy for breast cancer--how much is enough?
Journal of the National Cancer Institute 2007;99(24):1825-7.
2007: Vered Stearns; Qun Zhou; Nancy E Davidson
Epigenetic regulation as a new target for breast cancer therapy.
Cancer investigation 2007;25(8):659-65.
2007: Manfred Kaufmann; Gunter von Minckwitz; H D Bear; A Buzdar; P McGale; H Bonnefoi; M Colleoni; C Denkert; Wolfgang Eiermann; R Jackesz; Andreas Makris; W Miller; J-Y Pierga; Vladimir Semiglazov; Andreas Schneeweiss; Rainer Souchon; Vered Stearns; Michael Untch; Sibylle Loibl
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(12):1927-34.
2007: Ronald Ouwerkerk; Michael A Jacobs; Katarzyna J Macura; Antonio C Wolff; Vered Stearns; Sarah DAWOOD Mezban; NAGI KHOURI; David A Bluemke; Paul A Bottomley
Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23Na MRI.
Breast cancer research and treatment 2007;106(2):151-60.
2007: Susanne Briest; Vered Stearns
Chemotherapeutic Strategies for advanced breast cancer.
Oncology (Williston Park, N.Y.) 2007;21(11):1325-35; discussion 1338, 1340.
2007: Vered Stearns
Clinical update: new treatments for hot flushes.
Lancet 2007;369(9579):2062-4.
2007: Susanne Briest; Vered Stearns
Advances in the adjuvant and neoadjuvant treatment of breast cancer.
Women's health (London, England) 2007;3(3):325-39.
2007: Gary Elkins; Joel Marcus; Vered Stearns; M Hasan Rajab
Pilot evaluation of hypnosis for the treatment of hot flashes in breast cancer survivors.
Psycho-oncology 2007;16(5):487-92.
2007: Justin Stebbing; Vered Stearns; Nancy E Davidson
Role of CYP2D6 testing in selection of endocrine therapy for breast cancer.
Pharmacogenomics 2007;8(1):1-3.
2006: Vered Stearns
Raloxifene and tamoxifen had similar efficacy for preventing invasive breast cancer in women at increased risk.
Evidence-based medicine 2006;11(6):177.
2006: Vered Stearns
Raloxifene and tamoxifen had similar efficacy for preventing invasive breast cancer in women at increased risk.
ACP journal club 2006;145(3):72.
2006: Vered Stearns; Bryan Schneider; N Lynn Henry; Daniel F Hayes; David A Flockhart
Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants.
Nature reviews. Cancer 2006;6(11):886-93.
2006: Vered Stearns
More choices, more questions: weighing the options for treating hot flashes.
The journal of supportive oncology 2006;4(7):323-5.
2006: Ting Bao; Tatiana M Prowell; Vered Stearns
Chemoprevention of breast cancer: tamoxifen, raloxifene, and beyond.
American journal of therapeutics 2006;13(4):337-48.
2006: Silvana Borges; Zeruesenay Desta; Lang Li; Todd C Skaar; Bryan A Ward; Anne Nguyen; Yan Jin; Anna Maria Storniolo; D Michele Nikoloff; Lin Wu; Grant Hillman; Daniel F Hayes; Vered Stearns; David A Flockhart
Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment.
Clinical pharmacology and therapeutics 2006;80(1):61-74.
2006: Tatiana M Prowell; Vered Stearns
Disease-free survival was greater with letrozole than tamoxifen in postmenopausal women with early breast cancer.
ACP journal club 2006;145(1):11.
2006: Heather A Jacene; Vered Stearns; Richard L Wahl
Lymphadenopathy resulting from acute hepatitis C infection mimicking metastatic breast carcinoma on FDG PET/CT.
Clinical nuclear medicine 2006;31(7):379-81.
2006: Heather A Jacene; Takayoshi Ishimori; James M Engles; sophie leboulleux; Vered Stearns; Richard L Wahl
Effects of pegfilgrastim on normal biodistribution of 18F-FDG: preclinical and clinical studies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(6):950-6.
2006: Antonio C Wolff; Richard J Jones; Nancy E Davidson; Stacie C Jeter; Vered Stearns
Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim support.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(15):2392-4; author reply 2394-5.
2006: Tatiana M Prowell; Vered Stearns; Bruce J Trock
Lipophilic statins merit additional study for breast cancer chemoprevention.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(13):2128-9; author reply 2129.
2006: Manfred Kaufmann; Gabriel N Hortobagyi; Aron Goldhirsch; Suzy Scholl; Andreas Makris; Pinuccia Valagussa; Jens-Uwe Blohmer; Wolfgang Eiermann; Raimund Jackesz; Walter Jonat; Annette Lebeau; Sibylle Loibl; William Miller; Sigfried Seeber; Vladimir Semiglazov; Roy Smith; Rainer Souchon; Vered Stearns; Michael Untch; Gunter von Minckwitz
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1940-9.
2006: Vered Stearns
Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptoms.
Treatments in endocrinology 2006;5(2):83-7.
2005: Charles L Loprinzi; Vered Stearns; Debra L. Barton
Centrally active nonhormonal hot flash therapies.
The American journal of medicine 2005;118 Suppl 12B():118-23.
2005: Vered Stearns; Rebecca Slack; Nancy Greep; Ronda Henry-Tilman; Michael Osborne; Craig A Bunnell; Lynda Ullmer; Ann Gallagher; Jennifer Cullen; Edmund Gehan; Daniel F Hayes; Claudine Isaacs
Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):6919-30.
2005: Yan Jin; Zeruesenay Desta; Vered Stearns; Bryan Ward; Herbert Ho; Kyung-Hoon Lee; Todd C Skaar; Anna Maria Storniolo; Lang Li; Adjei Araba; Rebecca Blanchard; Anne Nguyen; Lynda Ullmer; Jill Hayden; Suzanne Lemler; Richard M Weinshilboum; James M Rae; Daniel F Hayes; David A Flockhart
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.
Journal of the National Cancer Institute 2005;97(1):30-9.
2005: James M Rae; Matthew P Goetz; Daniel F Hayes; James N Ingle; Lang Li; Anna Maria Storniolo; Vered Stearns; David A Flockhart
CYP2D6 genotype and tamoxifen response.
Breast cancer research : BCR 2005;7(5):E6.
2004: Vered Stearns; Ann Gallagher; Celina G Kleer; Baljit Singh; Matthew Freedman; Bassem R Haddad; Claudine Isaacs; Robert Warren; Martha Brown; Jennifer Cullen; Bruce J Trock; Daniel F Hayes
A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8332-40.
2004: Michael A Jacobs; Ronald Ouwerkerk; Antonio C Wolff; Vered Stearns; Paul A Bottomley; Peter B Barker; Pedram Argani; NAGI KHOURI; Nancy E Davidson; Zaver M Bhujwalla; David A Bluemke
Multiparametric and multinuclear magnetic resonance imaging of human breast cancer: current applications.
Technology in cancer research & treatment 2004;3(6):543-50.
2004: Vered Stearns; Andrew Coop; Baljit Singh; Ann Gallagher; Hideko Yamauchi; Ronald Lieberman; Marie Pennanen; Bruce J Trock; Daniel F Hayes; Matthew J Ellis
A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(22):7583-91.
2004: Gary Elkins; Joel Marcus; Lynne Palamara; Vered Stearns
Can hypnosis reduce hot flashes in breast cancer survivors? A literature review.
The American journal of clinical hypnosis 2004;47(1):29-42.
2004: Vered Stearns
Management of hot flashes in breast cancer survivors and men with prostate cancer.
Current oncology reports 2004;6(4):285-90.
2004: Vered Stearns; Nancy E Davidson
Déjà vu for breast cancer two?
Journal of the National Cancer Institute 2004;96(7):497-9.
2004: Leisha A Emens; Deborah K Armstrong; Barbara A Biedrzycki; Nancy E Davidson; JANICE DAVIS SPROUL; John H Fetting; Elizabeth M Jaffee; Beth Onners; Steven Piantadosi; Richard T. Reilly; Vered Stearns; Irena Tartakovsky; Kala Visvanathan; Antonio C Wolff
A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin.
Human gene therapy 2004;15(3):313-37.
2004: Vered Stearns; Nancy E Davidson; David A Flockhart
Pharmacogenetics in the treatment of breast cancer.
The pharmacogenomics journal 2004;4(3):143-53.
2003: Vered Stearns; Michael Johnson; James M Rae; Alan Morocho; Antonella Novielli; Pankaj Bhargava; Daniel F Hayes; Zeruesenay Desta; David A Flockhart
Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.
Journal of the National Cancer Institute 2003;95(23):1758-64.
2003: Vered Stearns; Katherine L Beebe; Malini Iyengar; Eric Dube
Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2003;289(21):2827-34.
2003: Vered Stearns; Charles L Loprinzi
New therapeutic approaches for hot flashes in women.
The journal of supportive oncology 2003;1(1):11-21; discussion 14-5, 19-21.
2003: Vered Stearns; Baljit Singh; Theodore Tsangaris; Jeanette G Crawford; Antonella Novielli; Matthew J Ellis; Claudine Isaacs; Marie Pennanen; Cecilia Tibery; Ahmad Farhad; Rebecca Slack; Daniel F Hayes
A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):124-33.
2002: Vered Stearns; Lynda Ullmer; Juan F Lopez; Yolanda R Smith; Claudine Isaacs; Daniel F Hayes
Hot flushes.
Lancet 2002;360(9348):1851-61.
2002: Matthew Ellis; Natalie Davis; Andrew Coop; Minetta Liu; Lisa Schumaker; Richard Y Lee; Rujirutana Srikanchana; Chris G Russell; Baljit Singh; William R Miller; Vered Stearns; Marie Pennanen; Theodore Tsangaris; Ann Gallagher; Aiyi Liu; Alan Zwart; Daniel F Hayes; Marc Lippman; Yue Wang; Robert Clarke
Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1155-66.
2002: Vered Stearns; Daniel F Hayes
Approach to menopausal symptoms in women with breast cancer.
Current treatment options in oncology 2002;3(2):179-90.
2002: Vered Stearns; C Alexander Ewing; Rebecca Slack; Marie F Penannen; Daniel F Hayes; Theodore Tsangaris
Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer.
Annals of surgical oncology 2002;9(3):235-42.
2002: Vered Stearns; Daniel F Hayes
Cooling off hot flashes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(6):1436-8.
2001: Daniel F Hayes; C Isaacs; Vered Stearns
Prognostic factors in breast cancer: current and new predictors of metastasis.
Journal of mammary gland biology and neoplasia 2001;6(4):375-92.
2001: H Yamauchi; Vered Stearns; Daniel F Hayes
When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2334-56.
2001: Claudine Isaacs; Vered Stearns; Daniel F Hayes
New prognostic factors for breast cancer recurrence.
Seminars in oncology 2001;28(1):53-67.
2001: H Yamauchi; Vered Stearns; Daniel F Hayes
The Role of c-erbB-2 as a predictive factor in breast cancer.
Breast cancer (Tokyo, Japan) 2001;8(3):171-83.
2000: Vered Stearns; Claudine Isaacs; J Rowland; J Crawford; M J Ellis; R Kramer; William Lawrence; John Hanfelt; Daniel F Hayes
A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(1):17-22.
1998: Vered Stearns; E P Gelmann
Does tamoxifen cause cancer in humans?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):779-92.
1998: Vered Stearns; H Yamauchi; Daniel F Hayes
Circulating tumor markers in breast cancer: accepted utilities and novel prospects.
Breast cancer research and treatment 1998;52(1-3):239-59.